Takahide Koda
Directeur/Membre du Conseil chez Cyrano Therapeutics, Inc.
Profil
Takahide Koda currently works as a Director at Cyrano Therapeutics, Inc.
Postes actifs de Takahide Koda
| Sociétés | Poste | Début |
|---|---|---|
Cyrano Therapeutics, Inc.
 Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Health Technology |
